GI
TAK icon

GAMMA Investing’s Takeda Pharmaceutical TAK Stock Holding History

GAMMA Investing’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$317K Buy
17,400
+3,563
+26% +$63.1K 0.01% 997
2026
Q2 		$222K Buy
13,837
+1,338
+11% +$22.1K 0.01% 1196
2026
Q1 		$231K Buy
12,499
+3,361
+37% +$59K 0.01% 1010
2025
Q4 		$142K Sell
9,138
-68
-0.7% -$972 0.01% 1301
2025
Q3 		$135K Buy
9,206
+152
+2% +$2.26K 0.01% 1259
2025
Q2 		$140K Buy
9,054
+2,012
+29% +$29.7K 0.01% 1171
2025
Q1 		$105K Buy
7,042
+1,296
+23% +$18.2K 0.01% 1215
2024
Q4 		$76.1K Sell
5,746
-549
-9% -$7.54K 0.01% 1320
2024
Q3 		$89.5K Buy
6,295
+3,629
+136% +$51.5K 0.01% 1073
2024
Q2 		$34.5K Sell
2,666
-198
-7% -$2.62K ﹤0.01% 1464
2024
Q1 		$39.8K Buy
2,864
+966
+51% +$14K 0.01% 1189
2023
Q4 		$27.7K Buy
+1,898
New +$26.9K 0.01% 1271

Other funds holding TAK

LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MLFP
MPS Loria Financial Planners Burr Ridge, Illinois $527M AUM 17.98% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
AP
Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return
RA
Riversedge Advisors Wilmington, Delaware $813M AUM 18.09% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return

GAMMA Investing's TAK Position: Q3 2026 in Review

GAMMA Investing increased its Takeda Pharmaceutical (TAK) stake by 26% in Q3 2026, buying an estimated $63.1K and bringing the position to 17,400 shares worth $317K. The position accounts for 0.01% of the portfolio, ranked #997.

GAMMA Investing first reported a position in TAK in Q4 2023 and has held it in 12 quarters since. 26 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • GAMMA Investing held 17,400 shares of Takeda Pharmaceutical worth $317K as of Q3 2026.
  • GAMMA Investing bought 3,563 Takeda Pharmaceutical shares in Q3 2026, an estimated $63.1K.
  • Takeda Pharmaceutical made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #997 holding.
  • GAMMA Investing first reported a position in Takeda Pharmaceutical in Q4 2023 and has held it in 12 quarters since.
  • 26 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.